Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome

Overview of attention for article published in BMC Cancer, January 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 19 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 6,670 followers.

Peking University (@PKU1898) researchers 👨‍🔬👩‍🔬 analyzed the dynamic changes of mixed-lineage leukemia-partial tandem duplications peri-transplantation and the best threshold for predicting relapse after transplantation. #OpenAccess here 👇 https://t.co/QL

07 Jan 2022

Reply Repost Favourite

RT @PaperbirdsM: New article: Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT i…

04 Jan 2022

Reply Repost Favourite

New article: Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome https://t.co/ZBgWAA2PQ1 #MDS #mdssm #hematology https://t.co/4ukjR

04 Jan 2022

Reply Repost Favourite

New article: Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome https://t.co/s3yRoNPjQy #AML #leusm #hematology https://t.co/H1t76

04 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.